Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-091650
Filing Date
2025-09-19
Accepted
2025-09-19 16:10:42
Documents
24
Period of Report
2025-11-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A pahc-20251104xdef14a.htm   iXBRL DEF 14A 1453546
2 GRAPHIC pahc-20251104xdef14a_a003.jpg GRAPHIC 13940
3 GRAPHIC pahc-20251104xdef14a_a004.jpg GRAPHIC 5131
4 GRAPHIC pahc-20251104xdef14a_a017.jpg GRAPHIC 62494
5 GRAPHIC pahc-20251104xdef14a_a018.jpg GRAPHIC 59834
6 GRAPHIC pahc-20251104xdef14a_a019.jpg GRAPHIC 60617
7 GRAPHIC pahc-20251104xdef14a_a020.jpg GRAPHIC 48511
8 GRAPHIC pahc-20251104xdef14a_bg001.jpg GRAPHIC 169980
9 GRAPHIC pahc-20251104xdef14a_cg001.jpg GRAPHIC 101379
  Complete submission text file 0001104659-25-091650.txt   4060261

Data Files

Seq Description Document Type Size
10 EX-101.SCH pahc-20251104.xsd EX-101.SCH 7313
11 EX-101.DEF pahc-20251104_def.xml EX-101.DEF 54245
12 EX-101.LAB pahc-20251104_lab.xml EX-101.LAB 5380
13 EX-101.PRE pahc-20251104_pre.xml EX-101.PRE 5721
26 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20251104xdef14a_htm.xml XML 450973
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 251326945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)